All single peptides A to Z30 peptides, with a chart for each vial size
All blendsA blend is two or more peptides mixed in one vial.
All stacksA stack is two separate vials used together. Each page gives both draws.
All guidesEvery tool runs in your browser. Nothing you type is sent anywhere.
6 peptides are filed under healing and recovery. None has an approved label in the US. Each page says whether its doses come from human trials or are only a reported range.
Peptides 6
Approved in the US 0
Authorized in Canada 0
Checked 10 Oct 2026| Peptide | Where the doses come from | How often | US | Canada |
|---|---|---|---|---|
| BPC-157 | Reported range, not a label dose | Once or twice daily | Not approved | Not authorized |
| TB-500 | Reported range, not a label dose | Twice weekly, then weekly | Not approved | Not authorized |
| KPV | Reported range, not a label dose | Once daily | Not approved | Not authorized |
| ARA-290 | Trial doses, no label | Once daily for 28 days | Not approved | Not authorized |
| MGF | Reported range, not a label dose | Once on training days | Not approved | Not authorized |
| Cartalax | Reported range, not a label dose | Once daily | Not approved | Not authorized |
US Not approved Canada Not authorized
The range reported for BPC-157 is 250 to 500 mcg once or twice a day by injection under the skin. No human study has tested that. The only human reports are three small ones, covering 2 to 16 patients each, and none of them injected it under the skin. It is not approved in the US or Canada.
US Not approved Canada Not authorized
The range reported for TB-500 is 2 to 2.5 mg twice a week, then once a week. There is no human dose on record: TB-500 is a 7 amino acid fragment, and every human trial used full-length thymosin beta-4 instead. It is not approved in the US or Canada.
US Not approved Canada Not authorized
The range reported for KPV is 200 to 500 mcg a day. No human study of KPV exists by any route, so that range has nothing in people behind it. The research is in cells and mice. It is not approved in the US or Canada.
US Not approved Canada Not authorized
No approved dose exists. In published phase 2 trials ARA-290 (cibinetide) was injected under the skin at 4 mg once a day for 28 days, and one trial compared 1, 4 and 8 mg a day. An earlier trial gave 2 mg into a vein three times a week. It is not approved in the US or Canada.
US Not approved Canada Not authorized
There is no established dose of MGF. No published human study has given the peptide at any dose, and the evidence is cell and animal work that one industry lab could not repeat. Reports describe 100 to 200 mcg after training, which is not a label dose. It is not approved in the US or Canada.
US Not approved Canada Not authorized
There is no established dose of Cartalax. No published human study of this peptide was found at any dose or by any route; the evidence is cell culture and rat work from one research group. Reports describe 2 to 5 mg a day, or 10 to 20 mg a day for 10 to 20 days, which is not a label dose. It is not approved in the US or Canada.
Weight loss and metabolicGrowth hormoneLongevityBrain and focusSkin and hairHormonal and sexual healthImmuneBlendsAll dosages A to Z
DosageFacts is an information site. It is not medical advice. Talk to a licensed professional before using any medication.